PT-141 (BREMELANOTIDE)

PT-141 works by activating melanocortin receptors (primarily MC3R and MC4R) in the hypothalamus and limbic system—the brain regions governing desire, reward, and motivation. This central mechanism means it enhances sexual desire at the neurological level, not just physical performance. Key mechanisms:

• MC3R/MC4R activation → sexual desire and arousal pathways in the brain

• Hypothalamic stimulation → central libido and motivation activation

• Dopaminergic influence → reward, motivation, and pleasure circuitry

• No vascular action → works independently of blood flow mechanics

PT-141 vs. PDE5 inhibitors (Viagra/Cialis):

• PT-141 = works on the brain (desire and arousal at the source)

• PDE5 inhibitors = works on blood vessels (physical erectile function only)

• PT-141 = effective for both men and women

Benefits

1. Sexual Desire & Libido (Primary Action)

• Significantly increases sexual desire in both men and women

• FDA-approved for HSDD in women (brand name: Vyleesi)

• Addresses the root of low desire, not just physical mechanics

2. Arousal Enhancement

• Heightens physical and emotional arousal

• Works centrally, not peripherally

• Effects typically onset within 1-2 hours of administration

3. Erectile Function Support (Men)

• Facilitates erections via central stimulation

• Complements PDE5 inhibitors for treatment-resistant ED

• Can be effective even without prior sexual stimulation

4. Emotional & Relational Intimacy

• Users report deeper emotional connection during intimacy

• May reduce performance anxiety through genuine desire response

• Supports overall relationship and sexual satisfaction

5. Women’s Sexual Health

• Specifically studied and clinically approved for women

• Addresses the desire gap that conventional treatments often miss

• Non-hormonal mechanism—suitable for various patient profiles